BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 23535326)

  • 1. Novel and highly potent histamine H3 receptor ligands. Part 3: an alcohol function to improve the pharmacokinetic profile.
    Labeeuw O; Levoin N; Poupardin-Olivier O; Calmels T; Ligneau X; Berrebi-Bertrand I; Robert P; Lecomte JM; Schwartz JC; Capet M
    Bioorg Med Chem Lett; 2013 May; 23(9):2548-54. PubMed ID: 23535326
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The discovery of the benzazepine class of histamine H3 receptor antagonists.
    Wilson DM; Apps J; Bailey N; Bamford MJ; Beresford IJ; Briggs MA; Calver AR; Crook B; Davis RP; Davis S; Dean DK; Harris L; Heightman TD; Panchal T; Parr CA; Quashie N; Steadman JG; Schogger J; Sehmi SS; Stean TO; Takle AK; Trail BK; White T; Witherington J; Worby A; Medhurst AD
    Bioorg Med Chem Lett; 2013 Dec; 23(24):6897-901. PubMed ID: 24161834
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Discovery of aryl ureas and aryl amides as potent and selective histamine H3 receptor antagonists for the treatment of obesity (part II).
    Gao Z; Hurst WJ; Guillot E; Czechtizky W; Lukasczyk U; Nagorny R; Pruniaux MP; Schwink L; Sanchez JA; Stengelin S; Tang L; Winkler I; Hendrix JA; George PG
    Bioorg Med Chem Lett; 2013 Jun; 23(11):3421-6. PubMed ID: 23591112
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel substituted pyrrolidines are high affinity histamine H3 receptor antagonists.
    Stocking EM; Aluisio L; Atack JR; Bonaventure P; Carruthers NI; Dugovic C; Everson A; Fraser I; Jiang X; Leung P; Lord B; Ly KS; Morton KL; Nepomuceno D; Shah CR; Shelton J; Soyode-Johnson A; Letavic MA
    Bioorg Med Chem Lett; 2010 May; 20(9):2755-60. PubMed ID: 20382018
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fluorinated non-imidazole histamine H3 receptor antagonists.
    Isensee K; Amon M; Garlapati A; Ligneau X; Camelin JC; Capet M; Schwartz JC; Stark H
    Bioorg Med Chem Lett; 2009 Apr; 19(8):2172-5. PubMed ID: 19286376
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis and SAR studies of benzimidazolone derivatives as histamine H3-receptor antagonists.
    Zeng Q; Rosenblum SB; Yang Z; Jiang Y; McCormick KD; Aslanian RG; Duguma L; Kozlowski JA; Shih NY; Hey JA; West RE; Korfmacher WA; Berlin M; Boyce CW
    Bioorg Med Chem Lett; 2013 Nov; 23(21):6001-3. PubMed ID: 24050887
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Discovery of aryl ureas and aryl amides as potent and selective histamine H3 receptor antagonists for the treatment of obesity (part I).
    Gao Z; Hurst WJ; Guillot E; Czechtizky W; Lukasczyk U; Nagorny R; Pruniaux MP; Schwink L; Sanchez JA; Stengelin S; Tang L; Winkler I; Hendrix JA; George PG
    Bioorg Med Chem Lett; 2013 Jun; 23(11):3416-20. PubMed ID: 23591110
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis and biological activity of novel tert-amylphenoxyalkyl (homo)piperidine derivatives as histamine H
    Kuder KJ; Łażewska D; Kaleta M; Latacz G; Kottke T; Olejarz A; Karcz T; Fruziński A; Szczepańska K; Karolak-Wojciechowska J; Stark H; Kieć-Kononowicz K
    Bioorg Med Chem; 2017 May; 25(10):2701-2712. PubMed ID: 28372935
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Discovery of a new class of non-imidazole oxazoline-based histamine H(3) receptor (H(3)R) inverse agonists.
    Célanire S; Wijtmans M; Christophe B; Collart P; de Esch I; Dassesse D; Delaunoy C; Denonne F; Durieu V; Gelens E; Gillard M; Lallemand B; Lamberty Y; Lebon F; Nicolas JM; Quéré L; Snip E; Vanbellinghen A; Van Houtvin N; Verbois V; Timmerman H; Talaga P; Leurs R; Provins L
    ChemMedChem; 2009 Jul; 4(7):1063-8. PubMed ID: 19405064
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Azole derivatives as histamine H3 receptor antagonists, part 2: C-C and C-S coupled heterocycles.
    Walter M; Isensee K; Kottke T; Ligneau X; Camelin JC; Schwartz JC; Stark H
    Bioorg Med Chem Lett; 2010 Oct; 20(19):5883-6. PubMed ID: 20727744
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of clinical candidates from the benzazepine class of histamine H3 receptor antagonists.
    Wilson DM; Apps J; Bailey N; Bamford MJ; Beresford IJ; Brackenborough K; Briggs MA; Brough S; Calver AR; Crook B; Davis RK; Davis RP; Davis S; Dean DK; Harris L; Heslop T; Holland V; Jeffrey P; Panchal TA; Parr CA; Quashie N; Schogger J; Sehmi SS; Stean TO; Steadman JG; Trail B; Wald J; Worby A; Takle AK; Witherington J; Medhurst AD
    Bioorg Med Chem Lett; 2013 Dec; 23(24):6890-6. PubMed ID: 24269482
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis and structure-activity relationship (SAR) study of 4-azabenzoxazole analogues as H3 antagonists.
    Shao N; Aslanian R; West RE; Williams SM; Wu RL; Hwa J; Sondey C; Lachowicz J; Palani A
    Bioorg Med Chem Lett; 2012 Mar; 22(5):2075-8. PubMed ID: 22326166
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Discovery of novel lead in the group of N-substituted piperazine ether derivatives with potential histamine H3 receptor activity.
    Kuder KJ; Stachnik M; Schunack W; Szymańska E; Kieć-Kononowicz K
    Med Chem; 2014; 10(6):588-99. PubMed ID: 24047214
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Non-imidazole histamine H3 receptor ligands incorporating antiepileptic moieties.
    Sadek B; Schwed JS; Subramanian D; Weizel L; Walter M; Adem A; Stark H
    Eur J Med Chem; 2014 Apr; 77():269-79. PubMed ID: 24650714
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Azole derivatives as histamine H3 receptor antagonists, part I: thiazol-2-yl ethers.
    Walter M; von Coburg Y; Isensee K; Sander K; Ligneau X; Camelin JC; Schwartz JC; Stark H
    Bioorg Med Chem Lett; 2010 Oct; 20(19):5879-82. PubMed ID: 20728354
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clobenpropit analogs as dual activity ligands for the histamine H3 and H4 receptors: synthesis, pharmacological evaluation, and cross-target QSAR studies.
    Lim HD; Istyastono EP; van de Stolpe A; Romeo G; Gobbi S; Schepers M; Lahaye R; Menge WM; Zuiderveld OP; Jongejan A; Smits RA; Bakker RA; Haaksma EE; Leurs R; de Esch IJ
    Bioorg Med Chem; 2009 Jun; 17(11):3987-94. PubMed ID: 19414267
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New lead elements for histamine H
    Espinosa-Bustos C; Frank A; Arancibia-Opazo S; Salas CO; Fierro A; Stark H
    Bioorg Med Chem Lett; 2018 Sep; 28(17):2890-2893. PubMed ID: 30025902
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of Histamine H
    Frandsen IO; Boesgaard MW; Fidom K; Hauser AS; Isberg V; Bräuner-Osborne H; Wellendorph P; Gloriam DE
    Sci Rep; 2017 Jul; 7(1):4829. PubMed ID: 28684785
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Discovery of novel steroidal histamine H
    Ledneczki I; Tapolcsányi P; Gábor E; Éles J; Greiner I; Schmidt É; Némethy Z; Kedves RS; Balázs O; Román V; Lévay G; Mahó S
    Bioorg Med Chem Lett; 2017 Oct; 27(19):4525-4530. PubMed ID: 28888822
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis and structure-activity relationships of 4,5-fused pyridazinones as histamine H₃ receptor antagonists.
    Tao M; Raddatz R; Aimone LD; Hudkins RL
    Bioorg Med Chem Lett; 2011 Oct; 21(20):6126-30. PubMed ID: 21906941
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.